CCDC22 antibody (N-Term)
Quick Overview for CCDC22 antibody (N-Term) (ABIN1449944)
Target
See all CCDC22 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- CCDC22 antibody was raised against an 18 amino acid synthetic peptide near the amino terminus of Human CCDC22
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CCDC22 (Coiled-Coil Domain Containing 22 (CCDC22))
-
Alternative Name
- CCDC22
-
Background
- CCDC22 is a recently identified coiled-coil domain-containing protein that has been shown to bind copines, which are calcium-dependent, membrane-binding proteins that may function in calcium signaling. In rat, CCDC22 has been observed to localize in multiple regions of the brain, including the prefrontal and somatosensory cortex, dentate gyrus and thalamus, and in the ipsilateral motor neurons of the spinal cord after sciatic nerve transection suggesting that it may play a role in neuronal injury response. The human CCDC22 gene has been identified as a novel candidate gene for syndromic X-linked intellectual disability (XLID).Synonyms: CXorf37, Coiled-coil domain-containing protein 22
-
Gene ID
- 28952
-
NCBI Accession
- NP_054727
Target
-